Analysts forecast that CryoPort Inc (NASDAQ:CYRX) will post ($0.07) earnings per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for CryoPort’s earnings, with the lowest EPS estimate coming in at ($0.08) and the highest estimate coming in at ($0.07). CryoPort posted earnings per share of ($0.08) during the same quarter last year, which indicates a positive year over year growth rate of 12.5%. The firm is expected to report its next earnings results on Tuesday, August 14th.
According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.29) per share for the current year, with EPS estimates ranging from ($0.31) to ($0.27). For the next fiscal year, analysts forecast that the firm will post earnings of $0.01 per share, with EPS estimates ranging from ($0.13) to $0.24. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow CryoPort.
Get CryoPort alerts:CryoPort (NASDAQ:CYRX) last announced its earnings results on Thursday, May 3rd. The consumer goods maker reported ($0.10) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.03). The business had revenue of $4.02 million for the quarter, compared to analyst estimates of $3.84 million. CryoPort had a negative return on equity of 48.12% and a negative net margin of 66.29%. The company’s quarterly revenue was up 48.3% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.10) earnings per share.
Several brokerages have recently weighed in on CYRX. BidaskClub raised CryoPort from a “hold” rating to a “buy” rating in a research note on Monday, May 14th. ValuEngine raised CryoPort from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 2nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $11.00 target price (up from $10.00) on shares of CryoPort in a research note on Thursday, March 8th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $11.63.
In related news, CEO Jerrell Shelton sold 29,257 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total value of $287,596.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 9.60% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Creative Planning acquired a new position in CryoPort in the 4th quarter valued at $5,176,000. Millennium Management LLC raised its stake in CryoPort by 205.0% in the 1st quarter. Millennium Management LLC now owns 434,068 shares of the consumer goods maker’s stock valued at $3,733,000 after purchasing an additional 291,737 shares during the last quarter. Taylor Wealth Management Partners raised its stake in CryoPort by 5.6% in the 4th quarter. Taylor Wealth Management Partners now owns 415,575 shares of the consumer goods maker’s stock valued at $3,570,000 after purchasing an additional 21,935 shares during the last quarter. OppenheimerFunds Inc. raised its stake in CryoPort by 20.6% in the 4th quarter. OppenheimerFunds Inc. now owns 406,829 shares of the consumer goods maker’s stock valued at $3,495,000 after purchasing an additional 69,571 shares during the last quarter. Finally, Allianz Asset Management GmbH raised its stake in CryoPort by 240.5% in the 4th quarter. Allianz Asset Management GmbH now owns 387,099 shares of the consumer goods maker’s stock valued at $3,325,000 after purchasing an additional 273,426 shares during the last quarter. 28.67% of the stock is owned by hedge funds and other institutional investors.
Shares of CryoPort traded up $1.19, hitting $12.02, during trading hours on Friday, Marketbeat Ratings reports. 1,160,486 shares of the company’s stock were exchanged, compared to its average volume of 224,674. The company has a market cap of $330.73 million, a price-to-earnings ratio of -35.35 and a beta of 0.71. CryoPort has a fifty-two week low of $3.08 and a fifty-two week high of $12.08.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
Get a free copy of the Zacks research report on CryoPort (CYRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com